Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
Lavakumar Karyampudi(Mayo Clinic), Keith L. Knutson(WinnMed), James Krempski(University of North Carolina at Chapel Hill), Barath Shreeder(Mayo Clinic), Purushottam Lamichhane(Mayo Clinic), Adam D. Scheid(Mayo Clinic), Marshall D. Behrens(Mayo Clinic), Kimberly R. Kalli(Mayo Clinic)
Cited by 156
Related Papers
Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells
|Cancer Research|2009|378
Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
|The Journal of Immunology|2011|250
Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
|The Journal of Experimental Medicine|2021|232
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
|The Lancet Oncology|2020|190
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
|Cancer Research|2017|169